{
  "id": 1768146554180,
  "seqId": 76,
  "title": "Herpes Viruses in Ophthalmology: HSV & HZO Clinical Guide",
  "summary": "An exhaustive clinical reference for the diagnosis and management of Herpes Simplex Keratitis and Herpes Zoster Ophthalmicus. This poster details viral pathogenesis, the spectrum of corneal involvement from epithelial to neurotrophic stages, and precise pharmacological treatment protocols.",
  "date": "2026-01-11T15:49:14.180Z",
  "data": {
    "title": "Herpes Viruses in Ophthalmology: HSV & HZO Clinical Guide",
    "summary": "An exhaustive clinical reference for the diagnosis and management of Herpes Simplex Keratitis and Herpes Zoster Ophthalmicus. This poster details viral pathogenesis, the spectrum of corneal involvement from epithelial to neurotrophic stages, and precise pharmacological treatment protocols.",
    "summary_illustration": "<svg viewBox='0 0 200 200' xmlns='http://www.w3.org/2000/svg'><circle cx='100' cy='100' r='80' fill='none' stroke='hsl(215, 90%, 45%)' stroke-width='2'/><path d='M60,100 Q100,20 140,100 Q100,180 60,100' fill='none' stroke='hsl(215, 90%, 45%)' stroke-width='2'/><circle cx='100' cy='100' r='15' fill='hsl(215, 90%, 45%)' opacity='0.3'/><path d='M85,85 L75,70 M115,85 L125,70 M85,115 L75,130 M115,115 L125,130' stroke='hsl(215, 90%, 45%)' stroke-width='2'/><path d='M100,80 L100,60 M100,120 L100,140' stroke='hsl(215, 90%, 45%)' stroke-width='2'/><path d='M120,100 L140,110 M140,110 L150,105' fill='none' stroke='hsl(215, 90%, 45%)' stroke-width='1.5'/><circle cx='150' cy='105' r='3' fill='hsl(215, 90%, 45%)'/></svg>",
    "sections": [
      {
        "title": "Viral Fundamentals: HSV1 vs HSV2",
        "icon": "biotech",
        "type": "table",
        "layout": "half_width",
        "color_theme": "blue",
        "content": {
          "headers": [
            "Feature",
            "HSV1",
            "HSV2"
          ],
          "rows": [
            [
              "Structure",
              "dsDNA Virus",
              "dsDNA Virus"
            ],
            [
              "Transmission",
              "Airborne",
              "Sexually Transmitted"
            ],
            [
              "Classic Sites",
              "Eyes, Face, Trunk",
              "Genital Herpes"
            ],
            [
              "Ophthalmic Frequency",
              "Primary cause of HSV keratitis",
              "Rare ophthalmic involvement"
            ]
          ]
        }
      },
      {
        "title": "HSV Pathogenesis & Latency",
        "icon": "account_tree",
        "type": "process",
        "layout": "half_width",
        "color_theme": "purple",
        "content": [
          "1. Primary Infection: Usually blepharoconjunctivitis, occasionally corneal involvement.",
          "2. Ascension: Virus ascends the sensory nerve axon.",
          "3. Latency: Resides in the trigeminal ganglion.",
          "4. Reactivation: Viral replication occurs.",
          "5. Migration: Retrograde migration to the cornea leads to recurrent keratitis (epithelial, stromal, endothelial, or neurotrophic)."
        ]
      },
      {
        "title": "Primary Infection: Blepharoconjunctivitis",
        "icon": "child_care",
        "type": "key_point",
        "layout": "full_width",
        "color_theme": "green",
        "content": [
          "HSV1 prevalence: 90% of the population are seropositive.",
          "Onset: Usually in childhood with generalized viral malaise; often ophthalmically silent.",
          "Common Manifestation: Self-limiting blepharoconjunctivitis.",
          "Clinical Signs: Periorbital vesicular rash, follicular conjunctivitis, and preauricular lymphadenopathy.",
          "Keratitis in 1° infection: Rare.",
          "Treatment (Prophylactic): Topical (Oc) aciclovir 3% 5×/d or oral aciclovir prophylaxis may be considered.",
          "Skin Treatment: Topical aciclovir 5% cream 3×/d."
        ]
      },
      {
        "title": "HSV Epithelial Keratitis: Clinical Features",
        "icon": "visibility",
        "type": "mindmap",
        "layout": "full_width",
        "color_theme": "blue",
        "content": {
          "center": "Epithelial Features",
          "branches": [
            "Symptoms: FB sensation, pain, blurred vision, lacrimation",
            "SPK & Stellate Erosion",
            "Dendritic Ulcer: Branching morphology with terminal bulbs (cf. pseudodendrites)",
            "Geographic Ulcer: Large amoeboid ulcer, dendritic edges (commoner in immunosuppression/topical steroids)",
            "Signs: Devitalized viral-infected epithelial cells; decreased corneal sensation",
            "Systemic: Associated orofacial or genital ulceration"
          ]
        }
      },
      {
        "title": "HSV Epithelial: Investigations & Staining",
        "icon": "science",
        "type": "table",
        "layout": "half_width",
        "color_theme": "yellow",
        "content": {
          "headers": [
            "Method",
            "Details/Findings"
          ],
          "rows": [
            [
              "Diagnosis",
              "Usually Clinical"
            ],
            [
              "Molecular",
              "PCR and ELISA from conjunctival/corneal swabs"
            ],
            [
              "Corneal Scrapings",
              "Giemsa stain showing multinuclear giant cells"
            ],
            [
              "Fluorescein",
              "Stains the ulcer base (de-epithelialized)"
            ],
            [
              "Rose Bengal",
              "Stains the ulcer margins"
            ]
          ]
        }
      },
      {
        "title": "HSV Epithelial Keratitis: Treatment",
        "icon": "medication",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "blue",
        "content": [
          "Topical Antiviral: Aciclovir 3% Oc 5×/d for 10–14d (continue 3d after healing).",
          "Resistant Cases: Trifluorothymidine 1% 9×/d (beware epithelial toxicity).",
          "Cycloplegia: Cyclopentolate 1% 2×/d for comfort/AC inflammation.",
          "Steroid Management: If on steroids for coexistent disease, reduce dose/potency where possible.",
          "Recurrent Attacks Prophylaxis: Oral aciclovir 400mg PO 2×/d for prolonged remission."
        ]
      },
      {
        "title": "Critical Warning: Corneal Grafts",
        "icon": "warning",
        "type": "red_flag",
        "layout": "full_width",
        "color_theme": "red",
        "content": [
          "Where HSV keratitis occurs in a corneal graft, reduction of topical steroids may increase the risk of graft rejection."
        ]
      },
      {
        "title": "HSV Stromal Keratitis",
        "icon": "layers",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "purple",
        "content": [
          "Presentation: May occur with or without epithelial ulceration.",
          "Signs: Multiple/diffuse opacities, corneal vascularization, lipid exudation, scarring, thinning, AC activity.",
          "Complications: Increased IOP, rarely perforation.",
          "Neovascularization Monitoring: Use fluorescein and ICG angiography to quantify/delineate if facilities available."
        ]
      },
      {
        "title": "HSV Stromal Keratitis: Treatment",
        "icon": "healing",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "green",
        "content": [
          "Topical Steroid: Defer until epithelium intact; minimum effective dose (e.g., prednisolone 0.1–1% 1–4×/d).",
          "Systemic Antiviral: Aciclovir 400mg 5×/d (initial), then reduce. Prophylactic dose: 400mg 2×/d.",
          "Systemic Benefit: Clear evidence for benefit and recurrence prevention (Consider for atopic keratoconjunctivitis, OSD, or frequent recurrences).",
          "Alternatives: Valaciclovir or famciclovir if aciclovir intolerant.",
          "Topical Aciclovir: 3% Oc 5×/d (controversial, but useful if epithelial breakdown present).",
          "Cycloplegia: Cyclopentolate 1% 2×/d.",
          "Surgery: Perforation (Tissue adhesive, tectonic graft); Scarring (DALK preferred over PK)."
        ]
      },
      {
        "title": "HSV Disciform Keratitis (Endotheliitis)",
        "icon": "emergency",
        "type": "mindmap",
        "layout": "full_width",
        "color_theme": "blue",
        "content": {
          "center": "Disciform Keratitis",
          "branches": [
            "Cause: Viral antigen hypersensitivity (rather than reactivation)",
            "Features: Painless, decreased VA, haloes",
            "Signs: Central/paracentral corneal oedema disc, Descemet’s folds, mild AC activity, fine KPs",
            "Wessely Ring: Stromal halo of precipitated viral antigen/host antibody",
            "Complications: Increased IOP, chronic anterior uveitis",
            "Investigation: AC paracentesis/PCR (diagnostic benefit if atypical; long-term aciclovir may cause false negatives)"
          ]
        }
      },
      {
        "title": "HSV Disciform Treatment Protocol",
        "icon": "medical_services",
        "type": "key_point",
        "layout": "full_width",
        "color_theme": "blue",
        "content": [
          "Topical Steroid: Defer until epithelium intact. Dexamethasone 0.1% or prednisolone 0.5% 1–4×/d. Titrate down. Some need maintenance (e.g., pred 0.1% alt—1×/d).",
          "Preservative-Free: Use if coexistent ocular surface disease.",
          "Antiviral: Systemic aciclovir (400mg 5×/d initially, then reduce to 400mg 2×/d prophylaxis). Continue until on low-dose steroid.",
          "Other: Cycloplegia (cyclopentolate 1% 2×/d); Monitor/Treat IOP."
        ]
      },
      {
        "title": "Herpes Zoster Ophthalmicus (HZO)",
        "icon": "lan",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "yellow",
        "content": [
          "Pathogen: VZV (dsDNA virus).",
          "Course: 1° infection (chickenpox) -> Latency in sensory ganglion -> Reactivation (shingles).",
          "Incidence: Ophthalmic branch of trigeminal nerve (Va) involved in 15% of shingles cases.",
          "Transmission: Direct contact or droplet spread.",
          "Vulnerable Groups: Immunosuppressed, elderly, pregnant women, neonates.",
          "Maternal Risk: 3% risk of fetal malformation in first trimester."
        ]
      },
      {
        "title": "HZO: Systemic & Cutaneous Disease",
        "icon": "personal_injury",
        "type": "mindmap",
        "layout": "half_width",
        "color_theme": "red",
        "content": {
          "center": "HZO Systemic Signs",
          "branches": [
            "Viral prodrome",
            "Preherpetic neuralgia: Mild tingling to electric pain",
            "Rash: Papules -> Vesicles -> Pustules -> Scabs (One dermatome [Va])",
            "Hutchinson’s sign: Tip of nose involvement (nasociliary nerve) indicating ocular risk",
            "Neurotrophic Cornea: Vulnerable to bacterial/fungal keratitis"
          ]
        }
      },
      {
        "title": "HZO Systemic Treatment",
        "icon": "pill",
        "type": "table",
        "layout": "full_width",
        "color_theme": "green",
        "content": {
          "headers": [
            "Medication",
            "Dosage",
            "Duration"
          ],
          "rows": [
            [
              "Aciclovir (Oral)",
              "800mg 5×/d",
              "5 days"
            ],
            [
              "Valaciclovir (Oral)",
              "1g 3×/d",
              "7 days"
            ],
            [
              "Famciclovir (Oral)",
              "750mg 1×/d",
              "7 days"
            ],
            [
              "Aciclovir (IV)",
              "10mg/kg 3×/d",
              "For immunosuppressed"
            ],
            [
              "Post-herpetic Neuralgia",
              "Amitriptyline, gabapentin, topical capsaicin cream",
              "N/A"
            ]
          ]
        }
      },
      {
        "title": "HZO Keratitis: Clinical Spectrum",
        "icon": "microbiology",
        "type": "table",
        "layout": "full_width",
        "color_theme": "blue",
        "content": {
          "headers": [
            "Type",
            "Onset",
            "Clinical Features"
          ],
          "rows": [
            [
              "Epithelial",
              "Acute (2–3d after rash)",
              "SPK + pseudodendrites, anterior stromal infiltrates. Common, resolves in weeks."
            ],
            [
              "Stromal",
              "Early (10d) or Late (3mo+)",
              "Nummular (granular deposits); Necrotizing (infiltrates, thinning, perforation). Rare."
            ],
            [
              "Disciform",
              "Late (3mo to years)",
              "Endotheliitis, corneal oedema, Descemet’s folds, AC activity, fine KPs. Chronic, uncommon."
            ],
            [
              "Neurotrophic",
              "Late onset",
              "Nerve damage, persistent epithelial defect, thinning, perforation. Chronic, uncommon."
            ],
            [
              "Mucus Plaques",
              "Late (3mo to years)",
              "Linear grey elevations, loosely adherent. Chronic."
            ]
          ]
        }
      },
      {
        "title": "HZO Ocular Management",
        "icon": "eye_tracking",
        "type": "key_point",
        "layout": "full_width",
        "color_theme": "purple",
        "content": [
          "Systemic: Ensure adequate systemic antiviral treatment.",
          "Epithelial: Topical lubricants (e.g., Celluvisc 0.5–1% 8×/d), usually preservative-free.",
          "Stromal & Disciform: Topical steroids (e.g., prednisolone 0.1–1% 1–4×/d); may need maintenance (0.1% alt—1×/d). Tectonic grafting/BCL for perforation.",
          "Neurotrophic: PF lubricants (carmellose 0.5–1% 8×/d + paraffin ointments nocte). Tarsorrhaphy (surgical or Botox), AMG, or conjunctival flap.",
          "Mucus Plaques: Mucolytics (acetylcysteine 5–10% PF 3×/d) or surgical debridement.",
          "Anterior Uveitis: Topical steroids (dexamethasone 0.1%) and cycloplegia (cyclopentolate 1% 2×/d).",
          "Monitor IOP: Assess if due to inflammation or steroids; treat accordingly.",
          "Corneal Scarring: Axial scarring may require PK."
        ]
      },
      {
        "title": "Associated Complications (HZO)",
        "icon": "list_alt",
        "type": "table",
        "layout": "full_width",
        "color_theme": "red",
        "content": {
          "headers": [
            "Category",
            "Complications"
          ],
          "rows": [
            [
              "Ocular",
              "Conjunctivitis, 2° microbial keratitis, glaucoma, anterior uveitis, episcleritis, scleritis, optic neuritis, cranial nerve palsies"
            ],
            [
              "Retinal",
              "Necrotizing retinitis: Acute Retinal Necrosis (ARN), Progressive Outer Retinal Necrosis (PORN)"
            ],
            [
              "Systemic",
              "Strokes (cerebral vasculitis), Neuralgia, Depression (even suicide risk)"
            ]
          ]
        }
      },
      {
        "title": "Pathogenesis & Risk Recap",
        "icon": "info",
        "type": "plain_text",
        "layout": "full_width",
        "color_theme": "blue",
        "content": "Potential intraocular involvement for HSV includes anterior uveitis and retinitis. The resultant neurotrophic cornea in both HSV and HZO is vulnerable to bacterial and fungal keratitis. In HZO, those never previously infected with VZV may contract chickenpox from contact with shingles cases."
      }
    ]
  },
  "chapterId": "cornea"
}